Keyphrases
1-measurement
16%
Antigen-specific
16%
Cancer Serum
16%
Carcinoembryonic Antigen
50%
Clinical Information
16%
Clinical Outcome Prediction
33%
Cochrane
16%
Current Therapeutics
16%
CYFRA 21-1
66%
Dynamic Change
16%
Immunotherapy Response
16%
Immunotherapy Therapy
100%
Literature Search
16%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
100%
Lung Cancer
16%
Marker Panel
16%
Medical Professionals
16%
Monitoring Value
16%
Neuron-specific Enolase
16%
Non-response
16%
Patient Serum
16%
Predictive Monitoring
16%
Predictive Prognostics
16%
Predictive Value
16%
Prognostic Value
16%
PubMed
16%
Response Monitoring
100%
Response Prediction
100%
Scoping Review
16%
Search Strategy
16%
Serum Tumor Markers
100%
Study Heterogeneity
16%
Targeted Therapy
100%
Therapeutic Landscapes
16%
Medicine and Dentistry
Carcinoembryonic Antigen
50%
Cytokeratin 19 Fragment
16%
Immunotherapy
100%
Lung Cancer
100%
Neuron Specific Enolase
16%
Patient Monitoring
16%
Study Heterogeneity
16%
Targeted Therapy
100%
Tumor Marker
100%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinoembryonic Antigen
50%
Cytokeratin 19 Fragment
16%
Immunotherapy
100%
Lung Cancer
100%
Neuron Specific Enolase
16%
Tumor Marker
100%
Biochemistry, Genetics and Molecular Biology
Carcinoembryonic Antigen
50%
Cochrane Library
16%
Enolase
16%
Keratin 19
16%
Medline
16%
Tumor Marker
100%